These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28964482)

  • 61. Risk-adapted Treatment for Severe B-Lineage Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation in Children.
    Giraldi E; Provenzi M; Conter V; Colledan M; Bolognini S; Foglia C; Sebastiani R; Fiocchi R; Gianatti A; DʼAntiga L; Rambaldi A
    Transplantation; 2016 Feb; 100(2):437-45. PubMed ID: 26270449
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Post-transplant lymphoproliferative disorders.
    Patel PR
    Clin Oncol (R Coll Radiol); 1999; 11(2):118-22. PubMed ID: 10378638
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring.
    Elidemir O; Kancherla BS; Schecter MG; McKenzie ED; Morales DL; Heinle JS; Mallory GB
    Pediatr Transplant; 2009 Aug; 13(5):606-10. PubMed ID: 19017289
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level.
    Eshraghian A; Imanieh MH; Dehghani SM; Nikeghbalian S; Shamsaeefar A; Barshans F; Kazemi K; Geramizadeh B; Malek-Hosseini SA
    World J Gastroenterol; 2017 Feb; 23(7):1224-1232. PubMed ID: 28275302
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014.
    Seçkin D
    G Ital Dermatol Venereol; 2014 Aug; 149(4):401-8. PubMed ID: 25068227
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
    Weintraub L; Weiner C; Miloh T; Tomaino J; Joashi U; Benchimol C; Strauchen J; Roth M; Wistinghausen B
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e481-6. PubMed ID: 24878618
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
    Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
    [TBL] [Abstract][Full Text] [Related]  

  • 68. FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
    Metser U; Lo G
    Br J Radiol; 2016; 89(1057):20150844. PubMed ID: 26544161
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Primary central nervous system post-transplant lymphoproliferative disorders].
    Honda M; Koga M; Kanda T
    Brain Nerve; 2014 Aug; 66(8):947-54. PubMed ID: 25082316
    [TBL] [Abstract][Full Text] [Related]  

  • 70. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Post-transplant lymphoproliferative disorders are not associated with IgG4 sclerosing disease.
    Cathro HP; Bullock GC; Bonatti H; Meriden Z; Cook S; Aguilera N
    Transpl Infect Dis; 2014 Dec; 16(6):897-903. PubMed ID: 25298125
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
    Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
    J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients.
    Mahale P; Engels EA; Lynch CF; Morton LM
    Br J Haematol; 2019 Jul; 186(2):347-351. PubMed ID: 30820931
    [No Abstract]   [Full Text] [Related]  

  • 75. Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.
    Reshef R; Luskin MR; Kamoun M; Vardhanabhuti S; Tomaszewski JE; Stadtmauer EA; Porter DL; Heitjan DF; Tsai de E
    Am J Transplant; 2011 Apr; 11(4):817-25. PubMed ID: 21401872
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Post-transplant lymphoproliferative disease: association with induction therapy?
    Dharnidharka VR
    Drugs; 2006; 66(4):429-38. PubMed ID: 16597161
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Post-transplant lymphoproliferative disorder of the cervical spine mimicking an epidural abscess.
    Wewel JT; Harbhajanka A; Kasliwal MK; Ahuja SK; Loew JM; Fontes RB
    J Clin Neurosci; 2016 Jul; 29():175-8. PubMed ID: 26916907
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stoma formation after lymphoproliferative disorders and immunosuppression therapy.
    Fulham J; Plucinski M
    Br J Nurs; 2018 Dec; 27(22):S20-S26. PubMed ID: 30525969
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review.
    Hernani R; Sancho A; Amat P; Hernández-Boluda JC; Pérez A; Piñana JL; Carretero C; Goterris R; Gómez M; Saus A; Ferrer B; Teruel AI; Terol MJ; Solano C
    Curr Res Transl Med; 2021 Oct; 69(4):103304. PubMed ID: 34303899
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients.
    Cheng J; Moore CA; Iasella CJ; Glanville AR; Morrell MR; Smith RB; McDyer JF; Ensor CR
    Clin Transplant; 2018 May; 32(5):e13235. PubMed ID: 29517815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.